Matthew Campbell to Insulin Detemir
This is a "connection" page, showing publications Matthew Campbell has written about Insulin Detemir.
Connection Strength
0.580
-
An additional bolus of rapid-acting insulin to normalise postprandial cardiovascular risk factors following a high-carbohydrate high-fat meal in patients with type 1 diabetes: A randomised controlled trial. Diab Vasc Dis Res. 2017 07; 14(4):336-344.
Score: 0.549
-
Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetes. Diabet Med. 2016 Apr; 33(4):506-10.
Score: 0.031